Exposure to pioglitazone and the risk of prostate cancer: a nested case-control studyFirst published 13/04/2016 Last updated 25/03/2024 EU PAS number: EUPAS11750StudyFinalised
ICON Commersialisation & Outcomes (MAPI-ICON), ICONGermany First published: 19/03/2010Last updated 06/03/2024 InstitutionNon-Pharmaceutical companyENCePP partner